|
67
|
233
|
4qvqM |
Ycp beta5-m45i mutant in complex with bortezomib |
|
66
|
242
|
4qw4D |
Ycp in complex with carfilzomib |
|
62
|
241
|
4qz0G |
Ycp beta5-m45v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
57
|
204
|
4qzxI |
Ycp beta5-c63f mutant in complex with the epoxyketone inhibitor onx 0914 |
|
73
|
212
|
4qwfK |
Ycp beta5-m45i mutant in complex with carfilzomib |
|
56
|
204
|
4qw6I |
Ycp beta5-m45v mutant in complex with carfilzomib |
|
59
|
226
|
4qvvH |
Ycp beta5-a49v mutant in complex with bortezomib |
|
71
|
250
|
4r67C |
Human constitutive 20s proteasome in complex with carfilzomib |
|
64
|
244
|
4qz7B |
Ycp beta5-a50v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
62
|
195
|
4qwsJ |
Ycp beta5-c63f mutant in complex with carfilzomib |
|
61
|
196
|
4qv5N |
Ycp beta5-m45i mutant |
|
66
|
250
|
4r00A |
Ycp beta5-c52f mutant in complex with omuralide |
|
62
|
196
|
4qluN |
Ycp in complex with tripeptidic epoxyketone inhibitor 9 |
|
59
|
222
|
4qz1L |
Ycp beta5-m45t mutant in complex with the epoxyketone inhibitor onx 0914 |
|
56
|
204
|
4qvwI |
Ycp beta5-a49s-mutant in complex with bortezomib |
|
70
|
242
|
4qv1D |
Ycp beta5-m45a mutant |
|
65
|
217
|
4r672 |
Human constitutive 20s proteasome in complex with carfilzomib |
|
61
|
195
|
4qz4J |
Ycp beta5-a49s mutant in complex with the epoxyketone inhibitor onx 0914 |
|
61
|
196
|
4qvyN |
Ycp beta5-a49t-mutant in complex with bortezomib |
|
66
|
233
|
4qz6M |
Ycp beta5-a49t-a50v double mutant in complex with the epoxyketone inhibitor onx 0914 |
|
65
|
231
|
4qwrE |
Ycp beta5-c52f mutant in complex with carfilzomib |
|
70
|
244
|
4qw1B |
Ycp beta5-a50v mutant in complex with bortezomib |
|
61
|
196
|
4qlqN |
Ycp in complex with tripeptidic epoxyketone inhibitor 8 |
|
60
|
195
|
4qzxJ |
Ycp beta5-c63f mutant in complex with the epoxyketone inhibitor onx 0914 |
|
72
|
212
|
4qxjK |
Ycp beta5-m45a mutant in complex with the epoxyketone inhibitor onx 0914 |
|
72
|
240
|
4qv8C |
Ycp beta5-c52f mutant |
|
54
|
199
|
4r3oK |
Human constitutive 20s proteasome |
|
58
|
222
|
4qwrH |
Ycp beta5-c52f mutant in complex with carfilzomib |
|
61
|
241
|
4qw3G |
Ycp beta5-c63f mutant in complex with bortezomib |
|
63
|
231
|
4qwsE |
Ycp beta5-c63f mutant in complex with carfilzomib |
|
59
|
222
|
4qluL |
Ycp in complex with tripeptidic epoxyketone inhibitor 9 |
|
62
|
222
|
4r02L |
Ycp in complex with bsc4999 (alpha-keto phenylamide) |
|
64
|
241
|
4qw7G |
Ycp beta5-m45t mutant in complex with carfilzomib |
|
57
|
204
|
4qv6I |
Ycp beta5-a49v mutant |
|
71
|
211
|
4r17K |
Ligand-induced aziridine-formation at subunit beta5 of the yeast 20s proteasome |
|
57
|
204
|
4qw5I |
Ycp beta5-m45a mutant in complex with carfilzomib |
|
59
|
222
|
4qvwL |
Ycp beta5-a49s-mutant in complex with bortezomib |
|
61
|
195
|
4qv3J |
Ycp beta5-m45v mutant |
|
69
|
240
|
4qz2C |
Ycp beta5-m45i mutant in complex with the epoxyketone inhibitor onx 0914 |
|
71
|
243
|
4qw1F |
Ycp beta5-a50v mutant in complex with bortezomib |
|
61
|
195
|
4qv5J |
Ycp beta5-m45i mutant |
|
60
|
195
|
4r17J |
Ligand-induced aziridine-formation at subunit beta5 of the yeast 20s proteasome |
|
67
|
233
|
4qz3M |
Ycp beta5-a49v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
64
|
240
|
4qwsC |
Ycp beta5-c63f mutant in complex with carfilzomib |
|
61
|
195
|
4qv7J |
Ycp beta5-a50v mutant |
|
57
|
222
|
4qzxH |
Ycp beta5-c63f mutant in complex with the epoxyketone inhibitor onx 0914 |
|
69
|
250
|
4qwgA |
Ycp beta5-a49v mutant in complex with carfilzomib |
|
69
|
240
|
4qwuC |
Ycp beta5-c52f mutant in complex with bortezomib |
|
59
|
196
|
4qw3N |
Ycp beta5-c63f mutant in complex with bortezomib |
|
69
|
240
|
4qzxC |
Ycp beta5-c63f mutant in complex with the epoxyketone inhibitor onx 0914 |
